» Articles » PMID: 40018606

Depressive Symptom Trajectories Among General Population During the COVID-19 Pandemic in Iceland: a Prospective Cohort Study (2020-2023)

Abstract

Introduction: While changes in the prevalence of depressive symptoms during the COVID-19 pandemic have been described across populations, few studies have incorporated multidimensional variables to characterise the varying effects of the pandemic on the population's mental health.

Methods: This cohort study included 6423 participants aged ≥18 years from the Icelandic COVID-19 National Resilience Cohort. Data on depressive symptoms and pandemic-related and non-pandemic-related factors were obtained during three pandemic assessment periods (baseline, follow-up wave 1 and follow-up wave 2; April 2020-December 2021), while health outcomes were obtained during the post-pandemic assessment period (follow-up wave 3; September 2022-February 2023). We used latent growth mixture models to identify variation in depressive symptom trajectories during the pandemic. We then used XGBoost models with 37 pandemic-related and non-pandemic-related factors to characterise these trajectories. Moreover, we performed linear regression to assess the association between the identified trajectories and post-pandemic health outcomes.

Results: Of the included participants, we identified four depressive symptom trajectories, including consistently low (83.7%), consistently high (5.3%), initially high (5.1%) and late-onset high (5.9%) symptom trajectories. Individuals who exercised frequently (≥3 days/week) and enjoyed social and family support were more likely to experience a consistently low symptom trajectory. In contrast, individuals with a history of psychiatric disorders, women and young adults (18-39 years) were less likely to follow the consistently low symptom trajectory. Moreover, compared with the consistently low symptom trajectory, the other trajectories were associated with significantly higher levels of depressive, anxiety and somatic symptoms and cognitive problems during the post-pandemic period.

Conclusions: Our results underscore the long-lasting impact of the COVID-19 pandemic on population mental health. Interventions focusing on exercise, social support and family support may mitigate the adverse mental health effects of future pandemics.

References
1.
Taxiarchi V, Senior M, Ashcroft D, Carr M, Hope H, Hotopf M . Changes to healthcare utilisation and symptoms for common mental health problems over the first 21 months of the COVID-19 pandemic: parallel analyses of electronic health records and survey data in England. Lancet Reg Health Eur. 2023; 32:100697. PMC: 10477036. DOI: 10.1016/j.lanepe.2023.100697. View

2.
Hawes M, Szenczy A, Klein D, Hajcak G, Nelson B . Increases in depression and anxiety symptoms in adolescents and young adults during the COVID-19 pandemic. Psychol Med. 2021; 52(14):3222-3230. PMC: 7844180. DOI: 10.1017/S0033291720005358. View

3.
Kimhi S, Eshel Y, Marciano H, Adini B, Bonanno G . Trajectories of depression and anxiety during COVID-19 associations with religion, income, and economic difficulties. J Psychiatr Res. 2021; 144:389-396. PMC: 8595304. DOI: 10.1016/j.jpsychires.2021.10.043. View

4.
Batterham P, Calear A, McCallum S, Morse A, Banfield M, Farrer L . Trajectories of depression and anxiety symptoms during the COVID-19 pandemic in a representative Australian adult cohort. Med J Aust. 2021; 214(10):462-468. PMC: 8207103. DOI: 10.5694/mja2.51043. View

5.
Kocalevent R, Hinz A, Brahler E . Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population. BMC Psychiatry. 2013; 13:91. PMC: 3606198. DOI: 10.1186/1471-244X-13-91. View